PRYZELOR Trademark

Trademark Overview


On Wednesday, March 23, 2016, a trademark application was filed for PRYZELOR with the United States Patent and Trademark Office. The USPTO has given the PRYZELOR trademark a serial number of 79195987. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 29, 2023. This trademark is owned by Novartis AG. The PRYZELOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
pryzelor

General Information


Serial Number79195987
Word MarkPRYZELOR
Filing DateWednesday, March 23, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 29, 2023
Registration Number5158602
Registration DateTuesday, March 14, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 27, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, November 16, 2016ASSIGNED TO EXAMINER
Thursday, November 10, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, November 14, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, November 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 17, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 22, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, December 7, 2016NOTICE OF PUBLICATION
Tuesday, December 27, 2016PUBLISHED FOR OPPOSITION
Tuesday, March 14, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, April 13, 2017GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, April 14, 2017FINAL DISPOSITION PROCESSED
Friday, April 14, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 5, 2017NOTIFICATION PROCESSED BY IB
Friday, September 29, 2023CANCELLED SECTION 71
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, June 28, 2024INVALIDATION PROCESSED
Friday, June 28, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB